Parkinson'
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. who are 30 years of age or older at the time of consent (regardless of gender) 2. who have been diagnosed with PD according to MDS diagnostic criteria 3. who have received a full explanation of their participation in this study, and who have given written consent of their own free will based on full understanding
Exclusion criteria
Exclusion criteria: 1. who have had a change in medication in the past month 2. neurological, orthopedic, and/or cardiovascular conditions that make them unsuitable for the e-sports program 3. visual or hearing impairments that would limit participation in the study 4. who have an MMSE score of less than 18/30 5. who are otherwise deemed unsuitable as research subjects by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in health-related quality of life assessed by the Parkinson's Disease Questionnaire-39 (PDQ-39) from baseline to 8 weeks, comparing the intervention and control groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety Recording of adverse events during the intervention period (continuously, up to 8 weeks). Acceptability Questionnaire based on the Theoretical Framework of Acceptability (intervention group only, at 8 weeks). Adherence Proportion of completed sessions out of the total 24 prescribed sessions (intervention group only, at 8 weeks). Feasibility Six-point Likert scale ratings of fatigue, effort, perceived progress, and enjoyment (intervention group only, at 8 weeks). Health-related quality of life 12-Item Short Form Health Survey (SF-12, PCS and MCS) (baseline and 8 weeks, between-group comparison). Motor function MDS-UPDRS Part III (baseline and 8 weeks, between-group comparison). Cognitive function Trail Making Test Part A (TMT-A) and Stroop Color and Word Test (SCWT) (baseline and 8 weeks, between-group comparison). Social engagement Lubben Social Network Scale-6 (LSNS-6) and Three-Item Loneliness Scale (TIL scale) (baseline and 8 weeks, between-group comparison). Semi-structured interviews | — |
Countries
Japan
Contacts
Kansai Medical University Department of Neurodegenerative Disorders